Dr. Vishnun Rao Veerapaneni, MBBS, MD (Chest), DCH, FCCP, is a pulmonologist, clinical innovator, and healthcare entrepreneur focused on advancing respiratory medicine through translational science. He is the Chairman and Managing Director of SWASA Hospitals India Pvt. Ltd., a leading center for allergy, asthma, and sleep-related breathing disorders serving both pediatric and adult populations. Driven by his vision of enabling “Freedom to Breathe,” he has expanded access to specialized respiratory care for more than 20,000 patients globally, including through telemedicine initiatives.
A recipient of the Young Scientist Award for Clinical Research in Asthma, Dr. Veerapaneni actively promotes the integration of clinical pulmonology with emerging scientific fields to better understand and treat chronic airway diseases.
As an Advisor to Nucliq Biologics, he provides strategic clinical guidance to research initiatives at the intersection of microbiome science, immunology, and respiratory health. Through collaboration with SWASA Hospitals, he supports translational research on the gut–lung axis, helping bridge clinical insights with microbiome-driven therapeutic innovation for allergic and respiratory diseases.